肾造口设备市场机会、成长动力、产业趋势分析与预测 2025 - 2034

2024 年全球肾造口设备市场价值为 13 亿美元，预计在 2025 年至 2034 年期间将以 8.5% 的复合年增长率强劲增长。这一增长可归因于肾臟相关疾病盛行率的上升，包括肾结石、泌尿道感染和肾积水。随着越来越多的人寻求针对这些情况的医疗干预，对有效排水解决方案的需求持续激增。此外，人们越来越倾向于微创手术，这推动了肾臟造口设备的普及。肾造口技术的创新，例如引入先进的材料和设计，以提高精度和安全性，进一步推动了市场的成长。

这些技术进步也提高了程序的有效性，使其更加安全、更有效率。对患者安全性和精准度的日益关注，推动了旨在减少肾造口治疗期间併发症的尖端设备的开发。随着全球医疗保健体系的发展，对最先进的肾臟造口设备的需求将持续上升，进一步促进市场扩张。医疗保健基础设施的不断发展，包括升级的影像技术，也在推动整个市场的发展方面发挥关键作用。

肾造口设备市场分为不同的产品类别，例如导引线、引流管、肾造口导管、鞘扩张器等。 2024 年，导丝部分创收 4.152 亿美元，成为市场最大的贡献者。导丝对于肾臟造口导管的准确放置至关重要，可在手术过程中提供灵活性和导航的便利性。亲水性涂层等创新提高了它们的可操作性，减少了併发症并确保了患者获得更好的治疗效果。此外，针对特定患者群体（如儿科或老年患者）设计的专用导丝越来越受欢迎，促进了该领域的持续成长。

在应用方面，市场分为肾结石、泌尿道感染、膀胱癌和其他。其中，肾结石市场占有最大份额，预计复合年增长率为 9.1%，到 2034 年达到 11 亿美元。肾结石是尿路阻塞的主要原因，通常需要进行肾造口术才能有效引流。由于不良的饮食习惯、脱水和久坐的生活方式等因素，肾结石的发生率不断上升，推动了对肾臟造口设备的需求。

在美国，肾造口设备市场规模在 2024 年达到 4.802 亿美元，预计 2025 年至 2034 年的复合年增长率为 7.8%。美国仍然是最大的市场，这主要是由于肾臟相关疾病（尤其是肾结石）发生率高。该国还受益于发达的医疗保健基础设施，其中包括可提高肾臟造口术成功率和精确度的先进成像技术。此外，主要市场参与者的存在和强劲的医疗保健支出进一步增强了美国市场的成长

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 肾臟疾病盛行率上升
    • 微创手术的采用率提高
    • 肾臟造口设备的技术进步
    • 提高民众意识
  • 产业陷阱与挑战
    • 与肾臟造口装置相关的风险
    • 替代程序的可用性
• 成长潜力分析
• 2024 年定价分析
• 报销场景
• 监管格局
• 技术格局
• 差距分析
• 波特的分析
• PESTEL 分析
• 未来市场趋势
• 价值链分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第 5 章：市场估计与预测：按产品，2021 年至 2034 年

• 主要趋势
• 导丝
• 引流管
• 肾造口导管
• 鞘管扩张器
• 其他产品

第 6 章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 肾结石
• 泌尿道感染
• 膀胱癌
• 其他应用

第 7 章：市场估计与预测：按病患类型，2021 – 2034 年

• 主要趋势
• 成人
• 儿科

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 诊所
• 门诊手术中心
• 其他最终用户

第 9 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• angiodynamics
• B. Braun
• BD
• Boston Scientific
• CardinalHealth
• Coloplast
• Cook
• Envaste
• meditech
• NeoMedical
• OLYMPUS
• rocamed
• Teleflex
• Uresil

The Global Nephrostomy Devices Market was valued at USD 1.3 billion in 2024 and is set to experience robust growth at a CAGR of 8.5% from 2025 to 2034. This growth can be attributed to a rising prevalence of kidney-related conditions, including kidney stones, urinary tract infections, and hydronephrosis. As more individuals seek medical intervention for these conditions, the demand for effective drainage solutions continues to surge. Additionally, there is a growing shift toward minimally invasive procedures, which is driving the increased adoption of nephrostomy devices. Innovations in nephrostomy technology, such as the introduction of advanced materials and designs that offer improved precision and safety, are further fueling market growth.

These technological advancements are also enhancing the effectiveness of procedures, making them safer and more efficient. The increased focus on patient safety and precision is propelling the development of cutting-edge devices aimed at reducing complications during nephrostomy treatments. As healthcare systems across the globe evolve, the demand for state-of-the-art nephrostomy devices will continue to rise, further promoting market expansion. The ongoing evolution of healthcare infrastructure, including upgraded imaging technologies, is also playing a key role in boosting the overall market.

The nephrostomy devices market is segmented into various product categories, such as guidewires, drainage tubes, nephrostomy catheters, sheath dilators, and others. In 2024, the guidewires segment generated USD 415.2 million, making it the largest contributor to the market. Guidewires are crucial for the accurate placement of nephrostomy catheters, offering flexibility and ease of navigation during procedures. Innovations like hydrophilic coatings have improved their maneuverability, reducing complications and ensuring better outcomes for patients. Additionally, specialized guidewires designed for specific patient demographics, such as pediatric or elderly patients, are gaining traction, contributing to the segment's continued growth.

On the application side, the market is divided into kidney stones, urinary tract infections, bladder cancer, and others. Among these, the kidney stones segment holds the largest share and is expected to grow at a CAGR of 9.1%, reaching USD 1.1 billion by 2034. Kidney stones are a leading cause of urinary blockages, often requiring nephrostomy procedures for effective drainage. The increasing incidence of nephrolithiasis, driven by factors such as poor dietary habits, dehydration, and sedentary lifestyles, is propelling the demand for nephrostomy devices.

In the U.S., the nephrostomy devices market reached USD 480.2 million in 2024 and is projected to grow at a CAGR of 7.8% from 2025 to 2034. The U.S. remains the largest market, driven by a high incidence of kidney-related disorders, particularly kidney stones. The country also benefits from a well-developed healthcare infrastructure, which includes advanced imaging technologies that enhance the success and precision of nephrostomy procedures. Moreover, the presence of leading market players and strong healthcare spending further reinforces the market's growth in the U.S.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of kidney disorders
    • 3.2.1.2 Increased adoption of minimally invasive surgical procedure
    • 3.2.1.3 Technological advancements in nephrostomy devices
    • 3.2.1.4 Increasing awareness among population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Risks associated with the nephrostomy devices
    • 3.2.2.2 Availability of substitute procedures
• 3.3 Growth potential analysis
• 3.4 Pricing analysis, 2024
• 3.5 Reimbursement scenario
• 3.6 Regulatory landscape
• 3.7 Technology landscape
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis
• 3.11 Future market trends
• 3.12 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Guidewires
• 5.3 Drainage tubes
• 5.4 Nephrostomy catheters
• 5.5 Sheath dilators
• 5.6 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Kidney stones
• 6.3 Urinary tract infections
• 6.4 Bladder cancer
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By Patient Type, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Adult
• 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Clinics
• 8.4 Ambulatory surgical centers
• 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 angiodynamics
• 10.2 B. Braun
• 10.3 BD
• 10.4 Boston Scientific
• 10.5 CardinalHealth
• 10.6 Coloplast
• 10.7 Cook
• 10.8 Envaste
• 10.9 meditech
• 10.10 NeoMedical
• 10.11 OLYMPUS
• 10.12 rocamed
• 10.13 Teleflex
• 10.14 Uresil